Global Cell & Gene Therapy Industry Market Analysis & Competitive Research (2023 – 2030)

The most effective and innovative research report on "Global Cell & Gene Therapy Market Research Report 2022-2030" gives the overall forecast and future prospects for the Cell & Gene Therapy Market. The report highlights major market programs, including top market players, latest Deployment Mode trends, key technical growth and development opportunities in the global Cell & Gene Therapy market, which helps for industry intelligence experts and investors make successful business decisions. In addition, the report is indicating on why interest is increasing for Cell & Gene Therapy and all important factors that contribute to overall market growth. The Global Statistical Survey Report of Cell & Gene Therapy is a described for the size of the market in the year 2023 and is expected to reach USD XX million from 2023 to 2030.
The Global Cell & Gene Therapy Market Research Report 2022-2030 covers market growth drivers and challenges, key market regulations’ information, analysis of new Products from the market leaders and key market trends, market share analysis for major players, supply chain and distribution analysis, Product and Deployment Mode trends, pricing information, emerging applications, technologies and major recent market developments. This information has also been provided for the major country markets in these regions. Market size and growth potential is assessed for these major country markets. Market growth drivers, restraints, government regulations, market share analysis by major competitors, recent major market developments (Product launches, M&A, partnerships, etc.) and other information have been covered for the major country markets listed in this section.
The study gives a short review of the Worldwide Cell & Gene Therapy in the present situation, and talks about the development of the Cell & Gene Therapy and its worldwide effect. It comprehensively segments the Cell & Gene Therapy by type, Deployment Mode and application. The Cell & Gene Therapy type and application market is additionally bifurcated by geologies and Verticals. Regions secured incorporate North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and Latin America; while application secured incorporate Hospitals, Cancer Care Centers, Wound Care Centers, and Others.
Market by type incorporates analysis as Cell Therapy and Gene Therapy. The Cell Therapy section is projected to steer the Cell & Gene Therapy market, in terms valuable, throughout the forecast amount.
This report additionally offers dominant part of the most recent and freshest industry information that covers the general market circumstance alongside future prospects for Cell & Gene Therapy Market around the globe. The examination think about incorporates huge information and furthermore figures of the Worldwide market which makes the report accommodating asset for promoting individuals, experts, industry officials, deals and item supervisors, and other individuals who need significant industry information in a prepared to-get to arrange alongside clear introduction of diagrams, pictures and tables.
North America is calculable to carry the most important market share and expected to dominate the Global Cell & Gene Therapy Market from 2023 to 2030. This region has the foremost dominance with property and well-established economies, empowering the region to powerfully invest in analysis and Development (R&D) activities, thereby contributory to the event of recent technologies in Cell & Gene Therapy Market security and analytics. Further, the government’s support and significant investments by numerous well-established organizations square measure driving the expansion of the market within the North American region.
Market player analysis of major companies such as AMGEN INC., BLUEBIRD BIO INC. , BRISTOL-MYERS SQUIBB CO. , DENDREON PHARMACEUTICALS LLC , GILEAD SCIENCES INC. , NOVARTIS INTERNATIONAL AG , ORCHARD THERAPEUTICS PLC. , PHARMICELL CO. LTD. , SIBIONO GENETECH CO. LTD. , VERICEL CORP...

Particular Scope
Region
  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • South America
Historic Year 2015 tо 2019
Estimated Year 2020
Forecast Year 2021 tо 2029

THE OBJECTIVES OF THIS STUDY

  • To define, describe, segment, and forecast the Market on the basis of Product Types, Grade Type, End Use Type, and across region.
  • To forecast revenue of the market segments with respect to main European countries
  • To identify the micro markets with respect to drivers, restraints, industry-specific challenges, opportunities, and trends affecting the growth of the market.
  • To strategically analyze market segments and sub segments with respect to individual growth trends, prospects, and contributions to the overall market.
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To profile the key players and comprehensively analyze their market position and core competencies in terms of market developments and growth strategies.
  • To track and analyze competitive developments such as partnerships, agreements, collaborations, and joint ventures; mergers and acquisitions; product launches; and research and development activities in the European market.

1 INTRODUCTION
1.1 OBJECTIVES
1.2 RESEARCH METHODOLOGY
1.2.1 SECONDARY DATA
1.2.2 PRIMARY DATA
1.2.3 MARKET SIZE ESTIMATION
1.2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
1.3 STAKEHOLDERS
1.4 RESEARCH ASSUMPTIONS
1.5 LIMITATION
2 EXECUTIVE SUMMARY
3 MARKET OUTLOOK
3.1 INTRODUCTION
3.2 OPPORTUNITIES MATRIX
3.3 MARKET CHALLENGES
3.4 MARKET SHARE ANALYSIS
3.5 VALUE CHAIN ANALYSIS
3.6 COVID-19 IMPACTS ON GLOBAL MARKET (DEMAND AND SUPPLY SIDE)
3.7 PORTER’S FIVE FORCES MODEL
3.7.1 DEGREE OF COMPETITION
3.7.2 BARGAINING POWER OF BUYERS
3.7.3 BARGAINING POWER OF SUPPLIERS
3.7.4 THREAT FROM SUBSTITUTES
3.7.5 THREAT FROM NEW ENTRANTS
4 CELL & GENE THERAPY TYPE ANALYSIS
4.1 INTRODUCTION
4.2 HISTORICAL MARKET TYPE ANALYSIS, 2017-2021
4.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2030
4.4 Y-O-Y GROWTH TREND ANALYSIS
4.5 CELL THERAPY
4.5.1 STEM CELLS
4.5.2 T CELLS
4.5.3 DENDRITIC CELLS
4.5.4 NK CELLS
4.5.5 TUMOR CELLS
4.6 GENE THERAPY
5 CELL & GENE THERAPY MARKET THERAPEUTIC CLASS ANALYSIS
5.1 INTRODUCTION
5.2 HISTORICAL MARKET THERAPEUTIC CLASS ANALYSIS, 2017-2021
5.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2030
5.4 Y-O-Y GROWTH TREND ANALYSIS
5.5 CARDIOVASCULAR DISEASE
5.6 CANCER
5.7 GENETIC DISORDER
5.8 RARE DISEASES
5.9 ONCOLOGY
5.10 HEMATOLOGY
5.11 OPHTHALMOLOGY
5.12 INFECTIOUS DISEASE
5.13 NEUROLOGICAL DISORDERS
6 CELL & GENE THERAPY MARKET DELIVERY METHOD ANALYSIS
6.1 INTRODUCTION
6.2 HISTORICAL MARKET DELIVERY METHOD ANALYSIS, 2017-2021
6.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2030
6.4 Y-O-Y GROWTH TREND ANALYSIS
6.5 IN VIVO
6.6 EX VIVO
7 CELL & GENE THERAPY MARKET END-USERS ANALYSIS
7.1 INTRODUCTION
7.2 HISTORICAL MARKET END-USERS ANALYSIS, 2017-2021
7.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2030
7.4 Y-O-Y GROWTH TREND ANALYSIS
7.5 IN HOUSE
7.6 OUTSOURCED
8 CELL & GENE THERAPY MARKET APPLICATION ANALYSIS
8.1 INTRODUCTION
8.2 HISTORICAL MARKET APPLICATION ANALYSIS, 2017-2021
8.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2030
8.4 Y-O-Y GROWTH TREND ANALYSIS
8.5 HOSPITALS
8.6 CANCER CARE CENTERS
8.7 WOUND CARE CENTERS
8.8 OTHERS
9 GLOBAL CELL & GENE THERAPY REGIONAL ANALYSIS
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2017-2021
9.2.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2030
9.2.3 Y-O-Y GROWTH TREND ANALYSIS
9.2.3.1 U.S.
9.2.3.2 Canada
9.2.3.3 Mexico
9.3 ASIA-PACIFIC
9.3.1 APAC HISTORICAL MARKET COUNTRY ANALYSIS, 2017-2021
9.3.2 Y-O-Y GROWTH TREND ANALYSIS
9.3.2.1 China
9.3.2.2 Japan
9.3.2.3 Korea
9.3.2.4 India
9.3.2.5 Rest of Asia-Pacific
9.4 MIDDLE EAST AND AFRICA
9.4.1 MIDDLE EAST AND AFRICA HISTORICAL MARKET COUNTRY ANALYSIS, 2017-2021
9.4.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2030
9.4.3 Y-O-Y GROWTH TREND ANALYSIS
9.4.3.1 Saudi Arabia
9.4.3.2 UAE
9.4.3.3 Egypt
9.4.3.4 Nigeria
9.4.3.5 South Africa
9.5 EUROPE
9.5.1 EUROPE HISTORICAL MARKET COUNTRY ANALYSIS, 2017-2021
9.5.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2030
9.5.3 Y-O-Y GROWTH TREND ANALYSIS
9.5.3.1 Germany
9.5.3.2 France
9.5.3.3 UK
9.5.3.4 Russia
9.5.3.5 Italy
9.6 SOUTH AMERICA
9.6.1 SOUTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2017-2021
9.6.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2030
9.6.3 Y-O-Y GROWTH TREND ANALYSIS
9.6.3.1 Brazil
9.6.3.2 Argentina
9.6.3.3 Columbia
9.6.3.4 Rest of South America
10 COUNTRY LEVEL ANALYSIS
10.1 UNITED STATES
10.2 CANADA
10.3 MEXICO
10.4 CHINA
10.5 JAPAN
10.6 INDIA
10.7 KOREA
10.8 SAUDI AREBIA
10.9 UAE
10.10 EGYPT
10.11 NIGERIA
10.12 SOUTH AFRICA
10.13 GERMANY
10.14 FRANCE
10.15 UK
10.16 RUSSIA
10.17 ITALY
10.18 BRAZIL
10.19 ARGENTINA
10.20 COLUMBIA
11 MARKET PLAYERS
11.1 ALNYLAM PHARMACEUTICALS INC.
11.1.1 BUSINESS OVERVIEW:
11.1.2 PRODUCT PORTFOLIO
11.1.3 REGIONAL REVENUE
11.1.4 RECENT DEVELOPMENTS
11.2 AMGEN INC.
11.3 BIOGEN INC.
11.4 CORESTEM INC.
11.5 DENDREON PHARMACEUTICALS LLC.
11.6 HELIXMITH CO. LTD.
11.7 JCR PHARMACEUTICALS CO. LTD.
11.8 KOLON TISSUEGENE INC.
11.9 NOVARTIS AG
11.10 PFIZER INC.
11.11 BLUEBIRD BIO INC.
11.12 BRISTOL-MYERS SQUIBB CO.
11.13 GILEAD SCIENCES INC.
11.14 ORCHARD THERAPEUTICS PLC.
11.15 PHARMICELL CO. LTD.
11.16 SIBIONO GENETECH CO. LTD.
11.17 VERICEL CORP.
11.18 SMITH NEPHEW (OSIRIS THERAPEUTIC)
11.19 ORGANOGENESIS
11.20 ROCHE (SPARK THERAPEUTICS)
12 ABOUT US

Table and Figure

Request For Customization

Purchase Option

Single User
$ 4585
340436.25
Multi User
$ 7585
563186.25
Enterprise User
$ 9585
711686.25

Still Need More Information? :